Back
Black Diamond Therapeutics Stock Predictions
This Company Didn't Survive the AI Reset-It Triggered It. You Can Still Get In Early.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering. Please read the offering circular and related risks at invest.radintel.ai. *RAD Intel recently received their ticker reservatio
Sell
42
BDTX
Black Diamond Therapeutics
Last Price:
$2.01
Seasonality Move:
27.74%
7 Day Trial
ALL ACCESS PASS
$
7
Disrupting a Trillion-Dollar Industry
Disclosure: *This is a paid advertisement for Boxabl's Regulation A offering. Please read the offering circular at invest.boxabl.com. This is a message from Boxabl.Black Diamond Therapeutics Stock Forecast
-
Is Black Diamond Therapeutics Stock Undervalued?The current Black Diamond Therapeutics [BDTX] share price is $2.01. The Score for BDTX is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
-
BDTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Black Diamond Therapeutics Stock Go Up Next Year?
Data Unavailable
Black Diamond Therapeutics Stock Rating
Data Unavailable
Black Diamond Therapeutics Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
blackdiamondtherapeutics.com
52-Week Data
52-Week High:
6.75
52-Week Low:
1.20
Prediction Charts
Market Cap:
114.3M
Price in USD:
2.01
Volume:
719.6K
Beta:
2.58
Technical Analysis
SMA50:
1.65
SMA100:
1.93
SMA200:
2.93
52-Wk Change:
-57.59%
Stock Predictions
-
Is Black Diamond Therapeutics stock public?Yes, Black Diamond Therapeutics is a publicly traded company.
-
What is the Black Diamond Therapeutics stock quote today?The Black Diamond Therapeutics stock price is 2.01 USD today.
-
How to buy Black Diamond Therapeutics stock online?You can buy Black Diamond Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| May-6 | 1.64 | 1.47 | 1.65 | 1.46 |
| May-7 | 1.57 | 1.55 | 1.57 | 1.49 |
| May-8 | 1.56 | 1.69 | 1.78 | 1.53 |
| May-9 | 1.70 | 1.64 | 1.73 | 1.61 |
| May-12 | 1.71 | 1.75 | 1.77 | 1.68 |
| May-13 | 1.94 | 1.93 | 1.98 | 1.75 |
| May-14 | 1.87 | 1.89 | 1.94 | 1.80 |
| May-15 | 1.81 | 1.93 | 1.95 | 1.77 |
| May-16 | 1.93 | 1.95 | 1.99 | 1.88 |
| May-19 | 1.92 | 2.11 | 2.13 | 1.90 |
| May-20 | 2.11 | 2.17 | 2.21 | 2.03 |
| May-21 | 2.15 | 2.03 | 2.19 | 1.98 |
| May-22 | 2.03 | 2.06 | 2.10 | 1.98 |
| May-23 | 2.02 | 2.01 | 2.04 | 1.95 |
Black Diamond Therapeutics Earnings
Data Unavailable
Black Diamond Therapeutics Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.01 per share, an increase this year of $1.58 per share, and a decrease next year of $1.07 per share.
* Black Diamond Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.